TotalMarketCap

Korsana Biosciences

KRSANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.376 B

$30.22 +0.36%

Close of 30 Oct 2026

As of 30 Oct 2026, Korsana Biosciences (KRSA) has a market capitalization of $1.38B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$2.07M

#3390 by revenue

Earnings

-$3.53M

Loss-making

Shares outstanding

4,681,351

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #130AnaptysbioANAB$1.44B
  2. #131Ascentage Pharma Group InternationalAAPG$1.39B
  3. #132Korsana BiosciencesKRSA$1.38B
  4. #133OmerosOMER$1.37B
  5. #134Damora TherapeuticsDMRA$1.36B

What if Korsana Biosciences were worth as much as…

Open the what-if tool →

Gold $27.0T

$593,751.51

Per share 19,648× higher

Bitcoin $1.55T

$34,124.85

Per share 1,129× higher

Nvidia $5.15T

$113,066.59

Per share 3,741× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Korsana Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 31 Oct 2026. Read the methodology.